Iberdomide Hydrochloride Patent Expiration
Iberdomide Hydrochloride was first introduced by Bristol Myers Squibb Co
Iberdomide Hydrochloride Patents
Given below is the list of patents protecting Iberdomide Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zenbexus | US11529339 | Combination Therapy For The Treatment Of Cancer | Sep 30, 2039 | Bristol Myers Squibb |
| Zenbexus | USRE49647 | Oct 07, 2034 | Bristol Myers Squibb | |
| Zenbexus | USRE50917 | Oct 07, 2034 | Bristol Myers Squibb | |
| Zenbexus | US9221788 | Salts And Solid Forms Of (S)-3-(4- (4-(Morpholinomethyl)Benzyl)Oxy)-1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione And Compositions Comprising And Methods Of Using The Same | Sep 25, 2033 | Bristol Myers Squibb |
| Zenbexus | US9629849 | Salts And Solid Forms Of (S)-3-(4-((4-(Morpholinomethyl)Benzyl)Oxy)-1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione And Compositions Comprising And Methods Of Using The Same | Aug 08, 2033 | Bristol Myers Squibb |
| Zenbexus | US8518972 | Arylmethoxy Isoindoline Derivatives And Compositions Comprising And Methods Of Using The Same | Jun 05, 2031 | Bristol Myers Squibb |
| Zenbexus | US9828361 | Arylmethoxy Isoindoline Derivatives And Compositions Comprising And Methods Of Using The Same | Feb 10, 2031 | Bristol Myers Squibb |
Iberdomide Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List